NPY and peripheral nerve injury: Further studies are needed to determine whether ablation or inhibition of Y1R-expressing neurons, with either intrathecal administration of NPY-saporin or optogenetic or chemogenetic inhibition of Y1R-expressing neurons utilizing cre driver lines, will inhibit established signs of neuropathic pain when administered days to weeks after peripheral nerve injury.